Kim Williams
Clinical trials for rare diseases face unique challenges, such as small patient populations and limited access to treatment options. With this in mind, behavioral science principles and technological advancements can help improve outcomes in rare disease clinical trials. Here are five ways behavioral science and technology can help: Enhance patient engagement with behavioral science principles …
Cell and gene therapy have been among the most promising medical technologies in recent years. As well as the potential to revolutionize the treatment of many diseases. However, the success of clinical trials for these therapies can be affected by a number of factors. These factors include patient recruitment and retention, adherence to treatment protocols, …
Medication adherence is a critical aspect of clinical trials. It can significantly impact the trial’s outcome and the ability to draw accurate conclusions from the data. Adherence refers to the extent to which a patient follows the prescribed treatment regimen, including taking medication, keeping appointments, and following other recommended therapies. For a clinical study to …
No two eCOA providers are the same, so how do you know what’s the right fit for you? In this article you’ll find considerations to take and questions to ask to find the right vendor for your CRO.
Read moreWhich eCOA/ePRO platform is the right fit for your CRO?